Company Search:
Advanced Search
Sponsored Links
Biomerieux SA Company Snapshot
Biomerieux SA operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomerieux SA with three other pharmaceutical manufacturers in Europe: Meda Ab of Sweden (2015 sales of 19.65 billion Swedish Kronor [US$2.20 billion] of which 62% was RX), Stada Arzneimittel AG of Germany (2.12 billion Euro [US$2.30 billion] of which 58% was Generics), and H. Lundbeck A/S which is based in Denmark (14.59 billion Danish Kroner [US$2.13 billion] of which 22% was Other Pharmaceuticals).

Sales Analysis. Biomerieux SA reported sales of 1.96 billion Euro (US$2.14 billion) for the year ending December of 2015. This represents an increase of 15.7% versus 2014, when the company's sales were 1.70 billion Euro. Sales at Biomerieux SA have increased during each of the previous five years (and since 2010, sales have increased a total of 45%). Sales of Diagnostic Clinical Equipment saw an increase that was more than double the company's growth rate: sales were up 374.6% in 2015, from 327.00 million Euro to 1.55 billion Euro. Biomerieux SA also saw significant increases in sales in Biofire Defense (up 106.7% to 24.80 million Euro) . Not all segments of Biomerieux SA experienced an increase in sales in 2015: sales of Microbiological Industrial Equipment fell 73.2% to 362.70 million Euro. Biomerieux SA also experienced decreases in sales in Co-Development Program (down 2.9% to 6.80 million Euro) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Biomerieux SA
  Stock Performance Chart for Biomerieux SA
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 138.40
(Figures in Euro)
1 Week 1.1%   13 Weeks 1.5%  
4 Weeks 11.5%   52 Weeks 33.9%  
Biomerieux SA Key Data:
  Ticker: BIM Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2015 Sales 1,964,600,000
(Year Ending Jan 2016).
Employees: 9,376
  Currency: Euro Market Cap: 5,399,165,767
  Fiscal Yr Ends: December Shares Outstanding: 39,453,166
  Share Type: Actions Ordinaires Closely Held Shares: 25,441,160
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.